Health Product Regulatory Authority SA (Saphra) has refuted claims it has cleared ivermectin for the treatment of Covid-19.
He said Soolantra cream – an Ivermectin product – has been approved for the treatment of a skin condition, unrelated to Covid-19.
Soolantra cream was not intended for the prevention or treatment of Covid-19, Saphra warned.
“The registration of Soolantra cream has the effect that the preparation is authorized in accordance with the provisions of Article 14 (4) of the Medicines Act, for example for specific patients, on the basis of a prescription of a doctor, ”Sahpra said.
Sahpra said she remains firm in her position that ivermectin can be prescribed and dispensed to patients without awaiting authorization under section 21, but is still subject to authorization by the section 21, informed consent and all the reporting requirements normally required under section 21.
In January, Sahpra announced that it would allow controlled compassionate use of ivermectin to treat Covid-19.
According to reports, there have not been many requests received for the compassionate use of ivermectin.
Sahpra noted earlier this month that fewer than 200 requests had been received for the treatment of Covid patients. | UKTN